The Diet That Can Provenly Reduce Cancer Risk
Study with More Than 79,000 Participants
A recent study by Loma Linda University in California provides new insights into the relationship between plant-based diets and the risk of various cancers. As part of the 'Adventist Health Study-2,' 79,952 adults in the U.S. and Canada were observed over an average of 7.3 years. The results suggest that a low-meat diet can reduce cancer risk. They were published in August 2024 in the American Journal of Clinical Nutrition.
At the start of the study, none of the participants had cancer. Researchers analyzed the health data of the subjects during the study and recorded around 7,300 newly diagnosed cancer cases. The data were evaluated concerning different dietary patterns—including meat-based, vegetarian, vegan, and pescatarian diets.
Vegetarians had up to a 45 percent lower risk of stomach cancer compared to regular meat eaters. The risk of lymphomas was also reduced by 25 percent. Vegans showed a 24 percent lower overall risk for all observed types of cancer. Particularly among younger men, the risk of prostate cancer was 43 percent lower for those following a vegan diet.
As this is an observational cohort study, no causal relationship can be proven. The authors note that other factors, such as body weight, lifestyle, or medical care, could also influence the results.1
A Study from 2022 Supports These Findings
According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide. However, 30 to 50 percent of all cases are preventable through preventive measures, including a healthy diet.2 A large-scale study by the University of Oxford in 2022 observed meat and fish eaters as well as vegetarians over eleven years. They discovered which dietary pattern—whether low or high in meat—can demonstrably reduce cancer risk.3
For their study, the scientists used data from 472,377 Britons from the UK Biobank, a biomedical database and research resource. Participants were divided into three categories based on questions about their diet:
Regular meat eaters (eat meat more than five times a week, 53 percent of participants)
Occasional meat eaters (eat meat five times or less a week, 44 percent of participants)
Pescatarians (eat fish, just over two percent of participants)
Vegetarians and vegans (eat neither meat nor fish, just under two percent of participants)
At recruitment, none of the subjects had cancer. Subsequently, the medical records of the participants were observed for eleven years. Other factors such as age, gender, smoking, alcohol consumption, and sociodemographic status were also considered.
Which Type of Diet Reduces Cancer Risk?
After an average of 11.4 years, the medical records of the study participants were evaluated. A total of 54,961 cancer cases were identified. Based on the dietary habits of the subjects, it was found: Compared to regular meat eaters, the cancer risk was two percent lower for those with a low-meat diet, ten percent lower for pescatarians, and 14 percent lower for vegetarians.
Risk for Specific Cancers Also Decreases
The annual number of new cases of all cancers is 493,250 (as of 2019/2020).4 In the United Kingdom, where the study was conducted, colorectal cancer, breast cancer, and prostate cancer are the most common types of cancer. In Germany, men most frequently develop prostate cancer, followed by lung and colorectal cancer, while women most frequently develop breast cancer, followed by colorectal and lung cancer.
Among the subjects, there were 5,882 cases of colorectal cancer, 7,537 cases of postmenopausal breast cancer, and 9,501 cases of prostate cancer. A clear correlation between cancer incidence and diet was observed.
Also interesting: How Diet Can Affect Menstruation–Positively or Negatively
Colorectal Cancer
People with a low-meat diet had a nine percent lower cancer risk for colorectal cancer compared to those who regularly consumed meat. This result aligns with a study published in 2015, which found that a higher intake of processed meat is associated with an increased risk of colorectal cancer.5 According to the World Cancer Research Fund (WCRF), red meat also increases the risk. Whole grains and dairy products, on the other hand, have a risk-reducing effect.6
Breast Cancer
Women who followed a vegetarian diet had an 18 percent lower risk of postmenopausal breast cancer compared to regular meat eaters. As the study authors explain, this could also be due to the generally lower average body weight of vegetarians. The WCRF warns that being overweight or obese in adulthood can increase the risk of postmenopausal breast cancer. Furthermore, according to the WCRF, there is evidence that consuming dairy products and non-starchy vegetables may reduce the risk of breast cancer.7
Prostate Cancer
Compared to regular meat eaters, pescatarians and vegetarians had a 20 percent and 31 percent lower risk, respectively, of developing prostate cancer. The study leaders suggest that, in addition to diet, other factors may play a significant role, such as whether a person undergoes cancer screening. This also applies to other types of cancer. The WCRF states that there is evidence that a high consumption of dairy products and a calcium-rich diet may increase the risk of prostate cancer.8
Limitations of the Study
Whether the observed correlations depend solely on diet cannot be definitively assured, according to the scientists. Other factors, such as personal lifestyle, etc., may have influenced the results.
Additionally, about 94 percent of the subjects were white, so it cannot be assumed that the same correlations can be found in other ethnic groups. It is also important to emphasize that abstaining from meat or following a low-meat diet does not automatically mean that a person is eating healthier.
How Much Meat Should Be on the Plate?
The study confirms once again: A balanced and low-meat diet, primarily consisting of vegetables, fruits, and whole grains, can reduce health risks such as cancer risk. While a purely pescatarian or vegetarian diet has a stronger effect, those who do not want to completely give up meat can still benefit their health by limiting the amount.
A large-scale umbrella review from 2024 analyzed study data from 2000 to 2023, which focused on vegetarian and vegan diets. Here, too, it was confirmed: A diet free of meat reduced the risk of developing cancer.9
Scientifically tested dietary principles, such as the nutrition circle of the German Nutrition Society, can be used as guidelines for a low-meat diet. These food-based dietary recommendations were updated in 2024. Per week, one to two servings of fish and meat of 120 grams each can be enjoyed. Two weekly servings of sausage of 30 grams each are also allowed.10
Grace, P., Abris, David, J, Shavlik., Roy, O, Mathew. et al. (2024). Cause-specific and all-cause mortalities in vegetarian compared with those in nonvegetarian participants from the Adventist Health Study-2 cohort. The American Journal of Clinical Nutrition ↩︎
Weltgesundheitsorganisation (WHO). Cancer. (accessed on July 15, 2024) ↩︎
Watling, C.Z., Schmidt, J.A., Dunneram, Y. et al. (2022). Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants. BMC Medicine. ↩︎
Robert Koch-Institut. Krebs in Deutschland für 2019/2020. (accessed on July 15, 2024) ↩︎
Bouvard, V., Loomis, D., Guyton, K. Z., et al. (2015). Carcinogenicity of consumption of red and processed meat. The Lancet Oncology. ↩︎
World Cancer Research Fund. (WCRF). Colorectal Cancer. (accessed on July 15, 2024) ↩︎
World Cancer Research Fund (WCRF). Breast Cancer. (accessed on July 15, 2024) ↩︎
World Cancer Research Fund (WCRF). Prostate Cancer. (accessed on July 15, 2024) ↩︎
Capodici,A., Mocciaro, G., Gori, D. et al. (2024). Cardiovascular health and cancer risk associated with plant based diets: An umbrella review. Plos One. ↩︎
Deutsche Gesellschaft für Ernährung. DGE-Ernährungskreis. (accessed on July 15, 2024) ↩︎
The post The Diet That Can Provenly Reduce Cancer Risk appeared first on FITBOOK.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Study finds link between metabolic syndrome, Parkinson's disease
Folks with metabolic syndrome have up to a 40% higher risk of developing Parkinson's disease, a new study says. Metabolic syndrome is a cluster of health problems that include excess belly fat, high blood pressure, elevated blood sugar and abnormal cholesterol levels. It's already known to increase people's risk of heart disease, stroke and type 2 diabetes. And now researchers have found an association between metabolic syndrome and Parkinson's, a degenerative nerve disease that primarily affects motor skills, according to findings published Wednesday in the journal Neurology. "Parkinson's disease is the second most common neurodegenerative disorder among older adults after Alzheimer's disease, and metabolic syndrome affects an estimated 1 in 4 adults and is highly modifiable," researcher Weili Xu, a professor in geriatric epidemiology at the Karolinska Institute in Stockholm, said in a news release. "Our findings suggest that metabolic syndrome may be a modifiable risk factor for Parkinson's disease," Xu said. For the study, researchers analyzed data for more than 467,000 participants in the UK Biobank, a large-scale health research project in the United Kingdom. Nearly 2 of 5 people (38%) had metabolic syndrome. Participants were followed for a median of 15 years, during which more than 3,200 developed Parkinson's disease. Median means half were followed longer, half for a shorter time. People with metabolic syndrome were about 40% more likely to develop Parkinson's than those without the syndrome, results show. Researchers also pooled their research with data gathered in eight previous studies, creating a group of nearly 25 million people with more than 98,500 cases of Parkinson's. In that meta-analysis, the team found a 29% increased risk of Parkinson's among people with metabolic syndrome. "We also found a higher risk of Parkinson's disease for people with both metabolic syndrome and a genetic susceptibility for Parkinson's disease," Xu said. "This suggests that maintaining metabolic health may be especially important for people who have genes that increase their risk for Parkinson's disease." Parkinson's occurs when the body's ability to produce the neurochemical dopamine is damaged or destroyed. A lack of dopamine causes the movement problems associated with the disease. Researchers said the health problems associated with metabolic syndrome might impair dopamine production in the body. High blood pressure and high cholesterol also might damage the tiny blood vessels in the brain, contributing to Parkinson's. Researchers noted that their findings could not prove a direct cause-and-effect link between metabolic syndrome and Parkinson's, only an association. "Future studies are needed to see whether working to control metabolic syndrome could help prevent Parkinson's disease," Xu concluded. More information The American Heart Association has more on metabolic syndrome. Copyright © 2025 HealthDay. All rights reserved. Play Farm Merge Valley


UPI
9 hours ago
- UPI
Study finds link between metabolic syndrome, Parkinson's disease
Karolinska Institute researchers in Sweden said their study found people with metabolic syndrome have up to a 40% higher risk of developing Parkinson's disease. File Photo by John Angelillo/UPI | License Photo Folks with metabolic syndrome have up to a 40% higher risk of developing Parkinson's disease, a new study says. Metabolic syndrome is a cluster of health problems that include excess belly fat, high blood pressure, elevated blood sugar and abnormal cholesterol levels. It's already known to increase people's risk of heart disease, stroke and type 2 diabetes. And now researchers have found an association between metabolic syndrome and Parkinson's, a degenerative nerve disease that primarily affects motor skills, according to findings published Wednesday in the journal Neurology. "Parkinson's disease is the second most common neurodegenerative disorder among older adults after Alzheimer's disease, and metabolic syndrome affects an estimated 1 in 4 adults and is highly modifiable," researcher Weili Xu, a professor in geriatric epidemiology at the Karolinska Institute in Stockholm, said in a news release. "Our findings suggest that metabolic syndrome may be a modifiable risk factor for Parkinson's disease," Xu said. For the study, researchers analyzed data for more than 467,000 participants in the UK Biobank, a large-scale health research project in the United Kingdom. Nearly 2 of 5 people (38%) had metabolic syndrome. Participants were followed for a median of 15 years, during which more than 3,200 developed Parkinson's disease. Median means half were followed longer, half for a shorter time. People with metabolic syndrome were about 40% more likely to develop Parkinson's than those without the syndrome, results show. Researchers also pooled their research with data gathered in eight previous studies, creating a group of nearly 25 million people with more than 98,500 cases of Parkinson's. In that meta-analysis, the team found a 29% increased risk of Parkinson's among people with metabolic syndrome. "We also found a higher risk of Parkinson's disease for people with both metabolic syndrome and a genetic susceptibility for Parkinson's disease," Xu said. "This suggests that maintaining metabolic health may be especially important for people who have genes that increase their risk for Parkinson's disease." Parkinson's occurs when the body's ability to produce the neurochemical dopamine is damaged or destroyed. A lack of dopamine causes the movement problems associated with the disease. Researchers said the health problems associated with metabolic syndrome might impair dopamine production in the body. High blood pressure and high cholesterol also might damage the tiny blood vessels in the brain, contributing to Parkinson's. Researchers noted that their findings could not prove a direct cause-and-effect link between metabolic syndrome and Parkinson's, only an association. "Future studies are needed to see whether working to control metabolic syndrome could help prevent Parkinson's disease," Xu concluded. More information The American Heart Association has more on metabolic syndrome. Copyright © 2025 HealthDay. All rights reserved.
Yahoo
11 hours ago
- Yahoo
ORMCO™ UNVEILS SPARK™ STAGERX™, THE NEXT EVOLUTION OF ALIGNER TREATMENT PLANNING
- Enhanced Treatment Accuracy Through a Powerful, Visual, and Streamlined Modular Workflow - BREA, Calif., Aug. 21, 2025 /PRNewswire/ -- Ormco Corporation, providing innovative products, solutions, and education to the orthodontic community for over 60 years, today announces the launch of Spark™ StageRx™, a groundbreaking visual workflow revolutionizing aligner treatment planning. This new tool not only improves clinical communication but also brings more efficiency to the doctor's workflow, enhancing treatment accuracy through standardized and modular protocols. "StageRx enables the peer-to-peer sharing of aligner protocols, fostering a vibrant community of aligner knowledge among practitioners, and 89% of doctors stating they are likely to recommend StageRx to their colleagues.1 Based on initial customer feedback, we are seeing this platform make a meaningful impact in practices," said Jay Issa, Vice President, Portfolio Management and Global Marketing, Ormco. "It comes with Spark Aligner protocols created by top global aligner experts, making it a helpful tool for both novice and advanced aligner doctors." Key Features & Benefits of Spark StageRx: Standardize communication with designers in a non-textual format. 84% of doctors agree StageRx has improved communication with treatment designers.¹ Protocol library provides select Spark standard and expert protocols, as well as your own creation for easy access and reuse. Visualize your setup with an easy drag and drop staging workspace. "This has completely transformed our clear aligner treatment planning process. It's visual, intuitive, and easy to use—you simply drag and drop," said Dr. Nadia Nizam.2 "The platform enables a smarter, more collaborative workflow by eliminating design inconsistencies and standardizing communication, all without sacrificing customization. My team can tailor treatment for each patient by modifying or adding steps, which are then submitted directly through the Spark DTX portal—ensuring both precision and consistency." For more information on Spark StageRx, visit Orthodontic Software | Spark™ Clear Aligner System | Ormco. About the Spark™ Clear Aligner SystemSpark Aligners are manufactured by Ormco, a global leader in innovative orthodontic products with 60 years of expertise, R&D, and high manufacturing standards. Ormco has helped doctors treat more than 20 million patients in more than 140 countries. Spark Approver Software is designed to give doctors more control and flexibility, while Spark's advanced aligner technology and TruGEN™ material provide more sustained force retention. Compared to the leading aligner brand and when contacting the same tooth, the Spark Aligner has 18% better surface contact with the tooth and is also designed to be more clear and more comfortable than the leading aligner brand and stain less than the leading aligner material -- which may be why 100% of patients recently surveyed said they would recommend Spark Aligners to a friend.3 For more information about Spark Aligners, visit About OrmcoEnvista is a global family of more than 30 trusted dental brands, including Ormco, Nobel Biocare, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Ormco, headquartered in Brea, Calif., is a global leader and innovator of orthodontic products and solutions to help enhance the lives of its customers and their patients. For more than 60 years, Ormco has partnered with the orthodontic community to help create over 20 million smiles in over 140 countries. Distinguished products range from twin brackets (Symetri™ Clear Brackets, Titanium Orthos™, and Mini Diamond™) to pioneering self-ligating appliances with the Damon™ System (including Damon Ultima™ System and Damon™ Clear2). The Spark™ Clear Aligner System is designed to meet the needs of the orthodontist with the TruGEN™ material and Approver Software. Ormco's Insignia™ Advanced Smile Design™ provides an all-inclusive customized indirect bonding solution for efficiency through personalization. From personalized service to professional education programs and marketing support, Ormco is committed to helping orthodontists achieve their clinical and practice management objectives. Connect on Facebook at and LinkedIn at 1Data on file. Based on a survey of doctors completed in February 2025.2Dr. Nadia Nizam is a paid consultant for Ormco. The opinions expressed are those of the doctor. Ormco is a medical device manufacturer and does not dispense medical advice. Clinicians should use their own judgment in treating their patients.3Marketing Confirmation Study-Data on File with Ormco Corporation. View original content to download multimedia: SOURCE Ormco Corporation Effettua l'accesso per consultare il tuo portafoglio